|Bid||4.68 x 900|
|Ask||5.97 x 1800|
|Day's Range||5.72 - 5.76|
|52 Week Range||5.61 - 8.00|
|Beta (5Y Monthly)||0.56|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 10, 2022 - Nov 14, 2022|
|Forward Dividend & Yield||0.28 (4.60%)|
|Ex-Dividend Date||Aug 23, 2022|
|1y Target Est||N/A|
Psychemedics ( NASDAQ:PMD ) Third Quarter 2022 Results Key Financial Results Revenue: US$6.52m (down 2.4% from 3Q...
ACTON, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the third quarter ended September 30, 2022. The Company also announced a cash quarterly dividend of $0.07 per share payable to the shareholders of record as of December 2, 2022, to be paid on December 16, 2022. The Company’s revenue for the quarter ended September 30, 2022, was $6.5 million versus $6.7 milli
From what we can see, insiders were net buyers in Psychemedics Corporation's ( NASDAQ:PMD ) during the past 12 months...